Growing at an Unbelievable Rate: Soleno Therapeutics Inc (SLNO) Stock
Piper Sandler raised the price target for the Soleno Therapeutics Inc (NASDAQ:SLNO) stock to “an Overweight”. The rating was released on February 05, 2024, according to finviz. The research report from Guggenheim has resumed the stock to Buy, with a price target set at $40. The stock was initiated by Guggenheim, who disclosed in a […]
Analysts Projected EPS of -$0.27 in the current quarter for Soleno Therapeutics Inc (NASDAQ:SLNO) Stock
Piper Sandler raised the price target for the Soleno Therapeutics Inc (NASDAQ:SLNO) stock to “an Overweight”. The rating was released on February 05, 2024, according to finviz. The research report from Guggenheim has resumed the stock to Buy, with a price target set at $40. The stock was initiated by Guggenheim, who disclosed in a […]
